ArticleEndocrine2026
Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma with calcifications: short-term imaging outcomes.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
objectiveTo evaluate the technical feasibility and short-term imaging evolution of ultrasound-guided thermal ablation for papillary thyroid microcarcinoma (PTMC) with calcification, while also analyzing the differences associated with calcification sizes.
methodsA total of 69 PTMCs with calcification were identified from 69 patients who underwent RFA or MWA between January 2022 and April 2025, and were retrospectively analyzed. The following outcomes were evaluated: technical success, changes in tumor volume and volume reduction rate (VRR), complete tumor disappearance, and complications.
resultsThe technical success rate was 100%. During a median follow-up of 15 months (range 6-33 months), significant differences in mean volume and VRR (versus baseline) were observed at all follow-up time points but not at the 3-month point. The overall complete disappearance rate was 43.5% (median 25 months), significantly higher and faster in the microcalcification group (55.3%; median 25 months) than that in the macrocalcification group (29.0%; median 30 months) (P = 0.029). The rate of overall complications was 2.9%, with no significant intergroup difference (2.6% vs. 3.3%, P = 1.000).
conclusionsUltrasound-guided thermal ablation for PTMC with calcification is technically feasible. On short-term sonographic assessment, although favorable changes were observed, the macrocalcification group showed a lower complete disappearance rate and a longer median time to disappearance.
Indexed as
Identifiers
42334783What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.